Clinical Trials Directory

Trials / Sponsors / Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Academic / Other · 9 registered clinical trials.

StatusTrialPhaseStarted
UnknownFolfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status
Advanced Colorectal Cancer
N/A2018-04-23
CompletedAbraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.
Pancreatic Cancer Stage II
Phase 22014-01-01
CompletedFirst-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cance
Colorectal Cancer Stage II
Phase 22013-05-01
TerminatedLow-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
Locally Advanced Unresectable Gastric Cancer, Metastatic Gastric Cancer
Phase 32013-01-01
CompletedSecond Line Chemotherapy for Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma
Phase 22010-01-01
CompletedTrial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients
Metastatic Colorectal Cancer
Phase 32009-09-01
UnknownMetastatic Advanced Pancreas Sorafenib
Locally Advanced Pancreatic Cancer
Phase 22007-08-01
CompletedFOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Canc
Colon Cancer
Phase 32007-06-01
CompletedGemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Ca
Pancreatic Cancer
Phase 22005-05-01